Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katalyst Laboratories is a private UK diagnostics company focused on distributing and supporting molecular and point-of-care diagnostic solutions rather than developing therapeutics. The company emerged from COVID-19 testing operations and states that it established an ISO 15189 laboratory in Soho Square, London, and an ISO 22870 point-of-care testing business in the UK. Its current commercial offering spans qPCR assays, lateral flow assays, ELISA-based tests, diagnostic instruments, reagents, and related support services for microbiology, virology, veterinary, environmental, food, and water testing markets. Katalyst also supports testing programs at healthcare and travel hubs and markets itself as an agnostic distributor working with products from multiple manufacturers. The business appears best characterized as a commercial diagnostics distributor and service provider rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katalyst Laboratories.